T1	Participants 287 332	limited-stage small cell lung cancer (LSCLC).
T2	Participants 553 567	LSCLC patients
T3	Participants 858 880	induction chemotherapy
T4	Participants 1142 1223	Thirty-seven and 40 patients were randomly assigned to study arm and control arm.
